ArticleAmerican journal of obstetrics & gynecology MFM2026
Association between diagnostic criteria of preeclampsia with severe features and adverse perinatal outcomes.
Article in American journal of obstetrics & gynecology MFM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPreeclampsia with severe features (PEC-SF) is a hypertensive disorder of pregnancy associated with significant maternal and perinatal morbidity. It is defined by heterogenous criteria, including severe hypertension and signs of end-organ dysfunction. Whether individual criteria confer differential risk for adverse perinatal outcomes remains unclear. This gap limits clinicians' ability to risk stratify patients, guide management decisions, and provide individualized counseling regarding prognosis.
objectiveTo estimate the association between individual diagnostic criteria in preeclampsia with severe features and adverse perinatal outcomes. STUDY
designThis is a retrospective cohort study of patients with antepartum PEC-SF who delivered at two academic medical centers from 2016-2017. Exposures included the number and type of severe criteria present at diagnosis. Our primary outcome was a composite of placental abruption, preterm birth < 34 weeks, a small for gestational age infant, or fetal demise. Secondary outcomes included preterm birth < 37 weeks, delivery type, or < 7 days of latency from diagnosis to delivery among those diagnosed at < 33 weeks. A multivariate logistic regression model adjusted for maternal age, race, and pre-existing medical conditions estimated the adjusted odds ratios (aOR) and 95% confidence interval (CI) for the primary outcome.
resultsThere were 704 patients with PEC-SF. Of these, 608 (86.4%) had severe hypertension, 246 (34.9%) reported neurological symptoms, and 332 (47.2%) presented with ≥ 2 severe criteria. Of 704, 371 (52.7%) had a single criterion, most often severe hypertension (81.1%). The primary outcome was associated with severe hypertension (aOR: 1.36, 95% CI: 1.22, 1.52), thrombocytopenia (aOR 1.28, 95% CI 1.13, 1.45), progressive renal insufficiency (aOR 1.16, 95% CI 1.03, 1.31), and impaired liver function (aOR 1.15, 95% CI 1.04, 1.28). Unplanned cesarean delivery was associated with severe hypertension (aOR:1.42, 95% CI: 1.02, 1.98) and impaired liver function (aOR: 1.13, 95% CI: 1.02, 1.25). The odds of the primary composite outcome increased with each additional criterion; among patients with severe hypertension, the association between the primary outcome was significant among those with two to three additional severe features (aOR 1.47, 95% CI 1.30, 1.67).
conclusionOur findings demonstrate that not all severe features carry equal odds of adverse pregnancy outcome and highlight the importance of considering both the type and number of criteria when risk stratifying patients and guiding clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.